Glaukos Corporation (GKOS)

NYSE · Healthcare · Medical Devices
$237.31-0.33%As of 2026-11-22 · USD
Last session low $233.40Last session high $244.54
52-week low $93.9652-week high $255.19
Market cap
$14.05B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)61.2In the neutral range (30 to 70)
MACD (12, 26, 9)14.82Below its signal line (16.62); histogram -1.80
Bollinger %B (20, 2)59%Inside the bands (185.97 to 273.45)
SMA 20229.71Price is 3.3% above
SMA 50190.95Price is 24.3% above
SMA 200150.33Price is 57.9% above
ATR (20)4.60% of priceAverage true range per day
52-week position89%In the upper part of the 93.96 to 255.19 range

About Glaukos Corporation

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

Insider filings, 90 daysNo purchases and 6 sales (about $14.5M).
Latest fiscal yearEnded 2025-12-31: revenue of $507.44M and an operating margin of -39.3%.

More in Medical Devices